SearchDictionaryMobileLogin

Contracture

5046  relevant articles (233 outcomes, 307 trials/studies) found for this Disease

Description: Prolonged shortening of the muscle or other soft tissue around a joint, preventing movement of the joint.

Also Known As:
Contractures

Relationship Network

Disease Context: Research Results

Related Diseases

1. Ischemia
2. Cicatrix (Scar)
3. Contracture
4. Malignant Hyperthermia
5. Wounds and Injuries (Trauma)

Experts

1. Zorn, Kevin C: 3 articles (02/2008 - 12/2006)
2. Zagaja, Gregory P: 3 articles (02/2008 - 12/2006)
3. Gofrit, Ofer N: 3 articles (02/2008 - 12/2006)
4. Prantl, Lukas: 3 articles (08/2007 - 07/2006)
5. Eisenmann-Klein, Marita: 3 articles (08/2007 - 07/2006)
6. Weisshorn, Ralf: 3 articles (09/2005 - 08/2002)
7. Wappler, Frank: 3 articles (09/2005 - 08/2002)
8. Fiege, Marko: 3 articles (09/2005 - 08/2002)
9. Reynolds, W Stuart: 2 articles (02/2008 - 01/2008)
10. Shalhav, Arieh L: 2 articles (02/2008 - 01/2008)

Drugs and Biologics

Drugs and Important Biological Agents (IBA) related to Contracture:
1. Caffeine (No Doz)FDA LinkGeneric
2. Halothane (Fluothane)FDA Link
3. CalciumIBA
4. Adenosine Triphosphate (ATP)IBA
5. Botulinum Toxins (Botulinum Toxin)IBA
6. L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA
02/01/2009 - "KR-31761 (10 microM) significantly increased the time to contracture during the ischemic period, whereas it concentration-dependently decreased the lactate dehydrogenase release during reperfusion. "
10/01/1999 - "heart rate, left ventricular developed pressure, coronary flow, double product and time to contracture formation) and biochemical (lactate dehydrogenase; LDH) parameters were evaluated. "
05/01/1993 - "Preconditioning caused significant improvements in reperfusion contractile function (25-fold increase in left ventricular developed pressure) and reductions in reperfusion lactate dehydrogenase release and reperfusion end diastolic pressure (contracture). "
02/01/2004 - "In isolated perfused rat hearts subjected to a 30-min global ischemia/30-min reperfusion, KR-31372 (1-10 microM) significantly improved severe contracture (end-diastolic pressure and time to contracture), markedly reduced reperfusion lactate dehydrogenase release, and enhanced the recovery of reperfusion contractile function (left ventricular developed pressure and double product) in a concentration-dependent manner compared with the vehicle-treated group. "
11/01/2003 - "IPC (n = 8) reduced reperfusion-induced lactate dehydrogenase release by 65.8% with respect to control hearts (n = 9) (P = 0.04) but had no effect on the time of onset of rigor contracture (increase in diastolic tension), electrical uncoupling (sharp changes in tissue resistivity and phase angle in impedance recordings), or block of impulse propagation during ischemia. "
Order ALL the reference details at left...
7. Lactic AcidFDA LinkGeneric
8. FlexorIBA
9. CollagenIBA
10. Dantrolene (Dantrium)FDA LinkGeneric

Therapies and Procedures

1. Transplants (Transplant)
2. Prostheses and Implants (Prosthesis)
3. Skin Transplantation (Skin Grafting)
4. External Fixators
5. Breast Implants (Breast Implant)

Best Treatments:
Research Summary Report
on Contracture

CureHunter Patient-Physician Summary Reports collect in one document all the medications ever reported in the US National Library of Medicine—1949 to the present—to be effective against your target disease. CureHunter research summary reports will vary in length from 25 to 250 pages. Analytic charts allow you and your physicians to see at a glance your medication options—including new, promising, off-label and experimental all rated for clinical efficacy.
  • Free Updates for 1 Year
  • All 233 Outcomes
  • Top 200 Key Drugs and Biologics
  • Top 50 Key Therapies and Procedures
  • Detailed History Charts
  • Full Research Reference Details
  • Sample PDF Report on Psoriasis >>
Price:$24.00 & Delivery via PDF download
updates for 1 year
Research Interface

 

Rapidly retrieve summaries of all the evidence for any disease in seconds. Save hours of search and analysis time. CureHunter is unlike any "search engine" you have ever used. Where standard "search engines" produce lists of links, CureHunter quantifies evidence, extracts it from the literature and calculates a result you can use to immediately facilitate evidence based decision making in Real Clinical Time.
  • Unlimited Disease, Drug and Therapy Search
  • 2 clicks from Disease to Drug to Evidence
  • Trial References
  • All the Positive Outcomes
  • Detailed Relationship Timeline Charts
  • Full Article Reference Details
  • Includes Mobile Interface Subscription
  • One-click to FDA Products/Patents
  • Request Institution License Details >>
Price:$490.00 access via web interface
1 year subscription
Proceed to Checkout >>
Mobile Interface

Retrieve summaries of all the evidence for any disease from your Mobile Phone or PDA. Accelerate decision making in the field. Speed up your study of new drug and disease domains. Refresh your knowledge on the road.
  • Access from any web enabled PDA or Phone
  • Trial references
  • All the Positive Outcomes
  • Drug and Therapy searches
  • Full Article Reference Details
  • Try Mobile Interface >>
Price:$45.00 access via "curehunter.com/m"
1 year subscription
Proceed to Checkout >>